Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.199
Delayed Data
As of Jul 02
 +0.0031 / +1.58%
Today’s Change
0.19
Today|||52-Week Range
0.40
-20.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues36.0K45.0K40.0K36.0K
 
 
 
 
 
Cost of Goods Sold18.0K153.0K100.0K121.0K
 
 
 
 
 
Depreciation And Amortization276.0K306.0K228.0K251.0K
 
 
 
 
 
 
Operating ExpensesGross Income-258.0K-414.0K-288.0K-336.0K
 
 
 
 
 
General Expenses4.8M3.9M4.3M4.6M
 
 
 
 
 
Research And Development2.3M1.9M2.4M2.7M
 
 
 
 
 
Total Operating Expenses5.1M4.4M4.6M5.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.1M-4.3M-4.6M-4.9M
 
 
 
 
 
Extraordinary Credit1.0K--13.0K0.00
 
 
 
Extraordinary Charge0.00---145.0K--
 
 
Interest Expense On Debt3.0K3.0K2.0K2.0K
 
 
 
 
 
Other Expenses0.000.000.001.4M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.0M-4.2M-4.5M-3.4M
 
 
 
 
 
Net Income-5.0M-4.2M-4.5M-3.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS185.7M190.7M204.0M213.6M
 
 
 
 
 
Shares To Calculate EPS Diluted185.7M190.7M204.0M213.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.02-$0.02-$0.02
 
 
 
 
 
EPS Diluted-$0.03-$0.02-$0.02-$0.02
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account